Atlas Trials

Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer

Clinical trial NCT00692900 · COMPLETED

Trial details

NCT number
NCT00692900
Sponsor
University of Pittsburgh
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Start date
2008-12-01
Primary completion
2013-06-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.